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Abstract. Ade R, Rai MK. 2010. Colchicine, current advances and future prospects. Nusantara Bioscience 2: 90-96. Colchicine is 
a toxic natural compound and secondary metabolite commonly produced by plants like Colchicum autumnale and Gloriosa superba. It 
is originally used to treat rheumatic complaints, especially gout, and still finds its uses for these purposes today despite dosing issues 
concerning its toxicity. It is also prescribed for its cathartic and emetic effects. Initially oral colchicine has not been approved as a drug 
by U.S. Food and Drug Administration (FDA). But now FDA approved colchicine as a drug for some disorders. Colchicine's present 
medicinal use is in the treatment of gout and familial mediterranean fever. It is also being investigated for its use as an anticancer drug. 
In neurons, axoplasmic transport is disrupted by colchicine. Due to all the pharmacological application of colchicine, there is urgent 
need to enhance the properties and increase the production of colchicine with the help of in vitro technologies. The present review is 
mainly focused on the chemistry of colchicine, its medicinal uses and toxicity.  
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Abstrak. Ade R, Rai MK. 2010. Kolkisin, kelebihannya pada saat ini dan prospeknya di masa depan. Nusantara Bioscience 2: 90-96. 
Kolkisin  adalah senyawa alami beracun dan metabolit sekunder yang umumnya dihasilkan oleh tanaman seperti Colchicum autumnale 
dan Gloriosa superba. Senyawa ini pada awalnya digunakan untuk mengobati keluhan rematik, terutama asam urat, dan tetap digunakan 
hingga kini, meskipun terdapat perdebatan mengenai dosis toksisitasnya. Senyawa ini juga diresepkan untuk efek katarsis dan emetik. 
Semula pemberian kolkisin secara oral sebagai obat belum disetujui oleh Badan Pengawas Obat dan Makanan Amerika Serikat (FDA), 
tetapi sekarang FDA menyetujui kolkisin sebagai obat untuk beberapa gangguan. Kolkisin digunakan dalam pengobatan asam urat dan 
demam mediterania familial. Senyawa ini juga sedang diselidiki kegunaannya sebagai obat antikanker, karena dalam neuron, 
transportasi akoplasma dapat dipengaruhi oleh kolkisin. Mengingat adanya aplikasi farmakologi kolkisin, maka perlu adanya upaya 
untuk memperbaiki sifat dan meningkatkan produksi kolkisin dengan bantuan teknologi in vitro. Telaah ini terutama difokuskan pada 
kimia kolkisin, serta penggunaannya sebagai obat dan toksisitasnya. 
Key words: kolkisin, fotoisomerisasi, colchicinamide, toksisitas, poliploidi. 
INTRODUCTION 
Colchicine is a traditional drug for gout (Wendelbo and 
Stuart 1985), and has been in use for treating acute gout 
dates back to 1810. It is obtained from corms of Gloriosa 
superba and also from Colchicum autmnale (Family 
Liliaceae). Since the approval of colchicine as drug for 
gout in 2009 by Food and Drug Administration (FDA, 
USA) there has been revival of interest in colchicine 
research and applications (Schlesinger 2010). Colchicine is 
an extremely poisonous alkaloid, originally extracted from 
Colchicum autumnale (autumn crocus, meadow saffron) 
medicinal plants. It is used to treat rheumatic complaints.  
Colchicine was first isolated in 1820 by the two French 
chemists Pelletier and Caventon and extract of Colchicum 
plant was first described as a treatment for gout in De 
Materia Medica of Padanius Dioscorides. It was later 
identified as a tri-cyclic alkaloid and its pain relieving and 
anti-inflammatory effects for gout were linked to its 
binding with the protein tubulin. The molecular formula of 
colchicine is C22H25NO6 and its chemical name is N-[ (7S)-
5, 6, 7, 9-tetrahydro-1, 2, 3, 10-tetramethoxy-9-
oxobenzo[a]heptalen-7-yl) acetamide].  
The term ‘colchicine’ is originated from area known as 
“Colchis” near black sea. C. autumnale grows wild in 
Europe and Africa while Gloriosa is distributed in Africa 
and Asia including foothills of Himalayas, Burma, 
Indonesia, Malaya, etc. Thomson was the first who 
proposed the early idea of action of colchicine in gout 
treatment. Gout and uric acid metabolism is same way 
linked and colchicine might act on this. Gout is caused by 
deposition of micro-crystals of uric acid in joints and may 
be due to defective regulatory mechanism for endogenous 
purine synthesis but conflicting results for the action of 
colchicine on synthesis and extraction of urates have been 
recorded. The colchicine interrupts the cycle of new 
deposition, which appears to be essential for the 
maintenance of acute gout. The frequent side effect has 
been recorded, but colchicine remains the ideal drug for 
acute gout. Modification of the side chain of rings does not 
eliminate anti-gout activity as long as the configuration of 
C-ring confirms to that of colchicine. It suppresses cell 
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division by inhibiting the development of spindles, from a 
pool of subunit during a distinct phase of cell cycle and 
then depolymerized during other phases.  
Colchicine can solve an important problem of fuchsia 
breeding. The maximum fuchsia species are diploid or 
tetraploid. The crossing between diploid and tetraploid 
results often in a triploid, which is mostly sterile because 
the process of meiosis requires the pairing of similar 
chromosomes and also due to lack of mechanism so as to 
allow the alignment of three similar chromosomes. Triploid 
plants are not able to produce prolific reproductive cells 
therefore they remain sterile and unusable like parents. The 
advantage of polyploidy plants that all plant parts are 
bigger (flowers, leaves) a lot of big double fuchsias are 
polyploidy. A special problem of colchicine which induced 
ploidy, particularly in vegetatively propagated crops, is the 
chimerism caused by the simultaneous occurrence of tissue 
of different ploidy levels in one plant or plant part.  
CHEMISTRY OF COLCHICINE 
Colchicine is also known as methyl ether of colchicine. 
It is a major alkaloid of Gloriosa superba and Colchicum 
autumnale. N-formyl-N-de-acetyl colchicine and 3-
demethyl colchicine designated as substances A, B, C 
respectively have occurred in lileaceae family (Figure 1). 
The study of isolation started in 1820 and present method 
of Ziesel-methoxyl determination has its foundation in the 
determination of these functional groups in colchicine 
possessing only one asymmetric carbon atom at position 
C7. The alkaloid morphine and strychnine are now known.  
Colchicine (C22H25NO4 ) is not an alkaloid, because the 
nitrogen atom is not basic, which is part of acetamide 
function, four oxygen atoms are present as 4-methoxy 
group, and remaining oxygen is unreactive towards reagent 
that affect acylation and affords no carbonyl derivative. 
Acid hydrolysis of colchicine in varying degrees of rigidity 
provides method used for the selective breaking cleavage 
of the functional groups. Dilute acid affords colchicine, an 
acidic substance that can be methylated to colchicine and 
iso-colchicine by diazo-methane. The assigned colchicine 
9-methyl phenanthrene structure and the structural formula 
for ring. Proof of cycloheptane structure for ring-B was 
obtained by synthesis of dl-colchinol methyl ether, N-
acetyl colchinol methyl anhydride, the degradation 
products of colchicine. Dewar (1945) reported troponol 
structure for ring -C and it was responsible for coining the 
term troponol for cycloheptiatrienolon., It was proved that 
ring -C was 7 member by the synthesis of octa-hydro 
demethoxy des oxides acetamid colchicine, a degradation 
product of colchicine in which ring C-remain intact, so the 
correct structure of colchicine is assigned as methyl ether 
of colchicine. Colchicine is optically active by virtue of the 
single asymmetric carbon atom at position C-7. The 
absolute configuration at this center was established by 
oxidation of colchicine to N-acetyl-L-glutamic acid. 
The synthesis of colchicine has attracted widespread 
attention as a synthetic object (Seganish et al. 2005). The 
starting material was 7-8-9 trimethoxy-benzo-suberone and 
end product was plus minus trimethylcolchicine acid which 
had been converted earlier to colchicine by resolution N-
acetylating and O-methylamine, while in case of Alexander 
et al. (1994) the starting material was purpurogallin 
trimethyl ether and end product is similar to Van tamelan 
synthesis. In Nakamura synthesis, starting material is 
pyrogallolmethyl ether herring A and C formed first and 
then constructed to form end product. 
 
 
 
 
Figure 1. Chemical structure of colchicine. 
 
 
Colchicinamide  
The well-designed synthesis of Woodward is 
conflicting and complete departure from the other 
approaches since it begins with the construction of a 
supplementary ring carbon atom 6, 7, 7a, 8, 12a and 
nitrogen atom of the future colchicine molecule. The N- 
atom masked in the stable isothiazole system until it is in 
the final step. Simple isothiazole was previously unknown. 
In this synthesis starting material substituted thiazole and 
end product al-colchicine.  
Photoisomerization  
 When colchicine is irradiated by light, photo-
isomerization occurs and structure of α-β-γ-lumicolchicine 
so formed has been elucidated. Now the process and 
methodology are currently at the cross road between the 
effectiveness of synthetic and natural compound in the 
improvement of human ailments. In comparison with 
allopathic or chemotherapy or antibiotic therapy, there are 
tremendous difficulties, allopathy has taken strong roots in 
most urban areas, the rural population of India has much 
faith in the usefulness and healing powers of age-old 
system of Ayurveda that is original system of medicines. 
Concentrated research in identifying and characterizing 
newer medicinal and aromatic plants can place us in a 
position of growth of National economy. Also we can help 
by fortifying the very grass root of Ayurveda by scientific 
interpretation to the pharmacodynamics of the many 
medicinal plant bases used in traditional treatments of the 
past. During the last three and half decades, various 
workers engaged in the field of Medicinal and Aromatic 
plants in India, have increased manifold and so the output 
of research data on the subject. There is similar stepping up 
in research and development work in the growing and 
processing of medicinal and aromatic plants in many other 
developing countries like Asia, Africa and Latin America 
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(Sudipto and Sastry 2000). This fact is powerfully reflected 
in the reports of many United Nation agencies, which has 
been advocating greater attention to those crops as a means 
of socio-economic uplift. However, in fact revitalization of 
interest in natural plant products as these are biologically 
more well-matched with human system and relatively less 
toxic than the synthesis. Thus, the growing of medicinal 
and aromatic plants has got a great boost during the last 
two decades. Evidently, need was felt for scientific 
literature on the growing and processing of these 
plants,.Under such a situation retrival of the information 
becomes a very painstaking process for the research and 
development.  
Nguyen et al. (2005) studied the common 
pharmacophor for a diverse set of colchicine site inhibitor 
using a structure-based approach. In which the modulation 
of structure and function of tubulin and microtubule is most 
important route to anticancer therapeutics therefore small 
molecule bind to tubulin and cause mitotic arrest are of 
enormous interest. A large number of synthetic and natural 
compounds with dissimilar structures have been shown to 
bind at the colchicine site, one of the major binding sites on 
tubulin, and inhibit tubulin assembly. Using the recently 
determined X-ray structure of the tubulin colchicinoid 
complex as the template, and also employed docking 
studies to determine the binding modes of a set of 
structurally diverse colchicine site inhibitors. These 
binding models were subsequently used to construct a 
comprehensive, structure-based pharmacopoeia. 
Raimond et al. (2004) reproted the tubulin regulation 
from a complex with colchicine and stathmin-like domain. 
The microtubules are cytoskeletal polymers of tubulin 
involved in many cellular functions. Their dynamic 
instability is controlled by numerous compounds and 
proteins including colchicine and stathmin family proteins. 
The way in which microtubule instability is regulated at the 
molecular level has remained controlled, mainly due to 
lack of appropriate structural data. The structure at 3.5 A 
resolution of tubulin in complex with colchicine and with 
the stathmin-like domain (SLD) of RB3 is the interaction 
of RB3-SLD with two tubulin heterodimers in a curved 
complex capped by the SLD amino-terminal domain, 
which prevents the incorporation of the complexe tubulin 
into microtubules. A comparison with the structure of 
tubulin in protofilaments shows change in the subunits of 
tubulin as it switches from its straight conformation to a 
curved one. These changes correlate with the loss of lateral 
contacts and provides a validation for the rapid microtubule 
depolymerization characteristic of dynamic instability. 
Moreover, the tubulin-colchicine complex sheds light on 
the mechanism of colchicine activity. Colchicine binds at a 
location where it prevents curved tubulin from adopting a 
straight structure, which inhibits assembly. 
Zhou et al. (2000, 2002) reported increasing embryogenesis 
and doubling efficiency by immediate colchicine treatment 
of isolated microspores in spring Brassica napus in which 
immediate colchicine treatment of isolated microspores 
with the concentrations 50 and 500 mg/L for 15 hour 
stimulated embryogenesis and produced large amounts of 
healthy-looking embryos. These normal embryos 
germinated well at 24ºC after being transferred to solid 
regeneration medium and an initial period of low 
temperature (2ºC) for 10 days, and could directly and 
rapidly regenerate vigorous plants. A high doubling 
efficiency of 83-91% was obtained from 500-mg/L 
colchicine treatments for 15 hour with low frequency of 
polyploid and chimeric plants. The experiment has shown 
that treatment duration of 30 hour revealed less positive 
effects on embryogenesis and doubling efficiency, 
especially at higher colchicine concentration (1000 mg/L). 
Poor embryogenesis and embryo germination were 
observed from ordinary microspore culture without change 
of induction medium and colchicine treatment, and several 
sub-cultures were required for induction of secondary 
embryogenesis and plant regeneration (Bourgaud et al. 
2001; Hadacek et al. 2002). 
PLANT SOURCE OF COLCHICINE 
Gigantic important flora has been a major source of 
secondary metabolites, which is now a main source of 
pharmaceuticals, food additives, fragrances and pesticides 
(Figure 2).  
Colchicum spp. 
Al-fayyad et al. (2002) studied determination of 
colchicine from Colchicum autumnale, and several others 
species, for example, in corms of Colchicum 
hierosolymitanum and Colchicum tunicatum colchicine was 
reported in an appreciable amount. The effect of different 
NPK (Nitrogen, Phosphorous and Potassium) fertilizer 
levels on colchicine content of the two colchicum species 
at different growth stages were evaluated by High 
Performance Liquid Chromatography. Results indicates 
that increasing NPK fertilizer levels significantly improve 
colchicine content in different plant parts and stages. The 
highest colchicine content observed in corms was at 
maturity stage 0.766 mg/g and 0.688 mg/g dry weight with 
C. hierosolimitanum and C. tunicatum respectively. 
Gloriosa superba 
Gloriosa superba is one of the important species in the 
world particularly, Asia and Africa produces two important 
alkaloids colchicine and gloriosin which is present in seeds 
and tubers (0.7% to 0.9%) and other is lumicolchicine, 3-
demethyl-N-deformyl-N-deacetylcolchicine, 3-
demethylcolchicine, N-formyldeacetylcolchcine have been 
isolated from the plant (Chulabhorn et al. 1998). It is used 
in almost all diseases, like cancer, gout, scrofula and act as 
antipyretic, antihelmintic, purgative and antiabortive. It is 
also source of gloriosin and colchicocides, which are very 
costly, being highly demanded by pharma industries. 
(Finnie and van Staden 1989; 1991). Due to excessive use 
of the plant for diverse medicinal purposes the species is on 
the verge of extinction and included in Red data book 
(Sivakumar et al. 2003a; 2003b; 2004; 2006). 
Gloriosa superba also known as Malbar glory lily is a 
perennial tuberous climbing herb, widely scattered in the 
tropical and sub-tropical parts of India. It is called as 
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‘Mauve beauty’, ‘Purple prince’, ‘Modest’, ‘Orange gem’, 
‘Salman glow’ and ‘Orange glow’ (Bose and Yadav 1989). 
It is adapted to different soil textures and climatic 
variations. The leaf juice is used to kill-lice in hair, the 
tuber contains the bitter principles, superbine and gloriosin, 
which in large doses are fatal ; however, in small doses 
they are used as tonic, antiabortive, and purgatives (Bellet 
and Gaignanlt 1985; Somani et al. 1989, Finnie and van 
Staden 1991; Samrajeewa 1993). The white flour prepared 
from the tubers is bitter and used as a stimulant. 
Ghosh et al. (2005; 2006) reported colchicine 
production by using aluminium chloride as an elicitor. Root 
cultures of Gloriosa superba were treated with 5 mM 
methyl jasmonate and 125 M AlCl3 which enhanced the 
intracellular colchicine content of the roots by 50-folds and 
63-folds respectively. 10 mM of CaCl2 and 1 mM CdCl2 
enhanced biomass significantly (7 to 8.6-fold respectively), 
while the maximum release of colchicine into the medium 
was obtained with 10 mM CdCl2. Casein hydrolysate, yeast 
extract and silver nitrate had no significant effect on 
growth and colchicine accumulation in root cultures. 
Muzaffar and Brossi (1991) investigated the chemical 
structures of colchicine and related analogs, including allo-
compounds with a six-membered ring. It was reported that 
colchicine cardiotoxicity by ingestion of Gloriosa superba, 
in which the clinical features of colchicine toxicity in a 
patient following ingestion of G. superba tubers were 
studied. Gastroenteritis, acute renal failure, cardiotoxicity 
and haematological abnormalities were the main toxic 
manifestations. There was no hypotension and no 
neurological manifestations. Electrocardiographic changes 
were noteworthy and have not been reported previously.  
Sivakumar et al. (2004) reported colchicine production 
in Gloriosa superba calli by feeding precursors, 
phenylalanine and tyrosine. The lack of biosynthetic 
precursors and signal inducing enzyme activity are 
responsible for the lower production of colchicine in vitro. 
B5 medium nutrient grown calli have a low content of 
colchicine indicating that an optimal precursor level is 
required to increase PAL and TAL activity for colchicine 
accumulation. These results suggest that precursors are an 
important regulatory factor in colchicine accumulation in in 
vitro. 
Other plants 
Jha et al. (2005) reported production of forskolin, 
withanolides, colchicine and tylophorine from plant source 
by using biotechnological approaches in which three 
alkaloids such as forskolin from Coleus forskohlii Briq, 
with anoloid from Withania somifera (L.) Dunal and 
colchicine from Gloriosa superba are discussed 
(Mukherjee et al. 2000; Furmanowa et al. 2001). The 
Coleus forskohlii Briq., a member of the family Lamiaceae 
is a common and ancient medicinal plant of India, and is 
used traditionally in Ayurvedic medicine (Bhattacharyya 
and Bhattacharya 2001; Engprasert et al. 2004). A large-
scale screening of medicinal plants by the Central Drug 
Research Institute, Lucknow, India, in 1974 revealed the 
presence of a hypotensive and spasmolytic component of 
C. forskohlii that was named coleonol. Further 
investigation (Saksena et al. 1985) determined 
micropropagation and in vitro culture for production of 
forskolin. Forskolin synthesis in transformed cultures 
transformed cell and organ cultures have proved valuable 
transformed cell suspension culture withanolides from W. 
somnifera. Cell and tissue culture of G. superba for 
production of colchicine. There are few reports on 
micropropagation of Gloriosa sp. Since the active principle 
is mainly concentrated in the tubers, multiplication of 
tubers in vitro is essential. In vitro tubers have several 
advantages. They are harder, easier to handle, can be 
transported dry, there is no dormancy period thereby year-
round cultivation is possible. These in vitro generated 
plantlets could serve as a source of cultures for studying the 
relationship between secondary metabolite accumulation 
and tissue different. The productivity of the culture systems 
(transformed/ untransformed) needs to be improved 
significantly and to be shown to be competitive with field 
plants for production of target secondary metabolites on an 
industrial scale (Brodelius et al. 1994). The lack of 
understanding of the molecular mechanism of regulation of 
secondary metabolism is the main bottleneck in attempts 
for further study. 
POISONING OF COLCHICINE  
Colchicine is often used to treat gout and acute 
rheumatoid arthritis and is known to relieve pain 
effectively (Neuwinger 1994). The mode of action of 
colchicine in gout is unknown, however, it is believed to 
decrease lactic acid production by the leukocytes and 
consequently, decrease urate crystal deposition and the 
subsequent reduction in phagocytosis with the 
inflammatory response. It also alters neuromuscular 
functions, intensifies gastrointestinal activity by neurogenic 
stimulation, increases sensitivity to central depressants, and 
depresses the respiration.  
Ingestion of colchicine typically leads to profuse 
vomiting and diarrhea, which can be bloody, followed by 
hypovolemic shock and multisystem organ failure within 
24-72 hours. Coma, convulsions, and sudden death might 
also occur. Subsequent complications include bone marrow 
suppression with resultant leukopenia, thrombocytopenia 
and possibly sepsis.  
Laboratory diagnosis 
There are two methods of detection of colchicine, (i) 
Biological- in which colchicine is detected in urine, serum, 
or plasma as determined by a commercial laboratory, and 
(ii) Environmental - colchicine in environmental samples 
can be determined as per rules of Food and Drug 
Administration.  
Case classification 
Suspected: A case in which a potentially exposed 
person is being evaluated by health-care workers or public 
health officials for poisoning by a particular chemical 
agent, but no specific credible threat exists. 
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Figure 1. Several main plant source of colchicines. A. Colchicum autumnale, B. Gloriosa superba, C. Coleus forskohlii. (photos from 
several sources) 
 
 
 
Probable: A clinically compatible case in which a high 
index of suspicion (credible threat or patient history 
regarding location and time) exists for colchicine exposure 
or an epidemiologic link exists between this case and a 
laboratory-confirmed case.  
Confirmed: A clinically compatible case in which 
laboratory tests have confirmed exposure.  
Colchicine is FDA-approved drug in USA recently for 
the treatment of gout and also for familial Mediterranean 
fever, amyloidosis, and scleroderma (Kallinich et al. 2007). 
Side effects include gastro-intestinal upset and neutropenia. 
Starting the drug early during an attack of gout can 
exacerbate the symptoms. High doses can also damage 
bone marrow and lead to anemia. It's not used in the 
treatment of cancer, as the dose required would lead to 
intolerable side effects.  
Toxicity 
Poisoning resembles intoxication with arsenic: 
symptoms start 2 to 5 hours after the toxic dose has been 
ingested and include burning in the mouth and throat, 
fever, vomiting, abdominal pain and kidney failure. Death 
from respiratory failure can follow (Goldbart et al. 2000). 
There is no remedy. It was later identified as a tricyclic 
alkaloid and its pain relieving and anti-inflammatory 
effects for gout were linked to it binding with the protein 
tubulin. It inhibits the cytoskeleton by binding to tubulin, 
one of the main constituents of microtubules. Apart from 
inhibiting mitosis, a process heavily dependent on 
cytoskeletal changes, it also inhibits neutrophil motility and 
activity, leading to a net anti-inflammatory effect.  
COLCHICINE IN CELL DEVELOPMENT 
Pharmacology 
Colchicine inhibits microtubule polymerization by 
binding to tubulin, one of the main constituents of 
microtubules. Availability of tubulin is essential to mitosis, 
and therefore colchicine effectively functions as a "mitotic 
poison" or spindle poison. Since one of the defining 
characteristics of cancer cells is a significantly increased 
rate of mitosis, this means that cancer cells are significantly 
more vulnerable to colchicine poisoning than normal cells. 
However, the therapeutic value of colchicine against cancer 
is limited by its toxicity against normal cells. 
Apart from inhibiting mitosis, a process heavily 
dependent on cytoskeletal changes, colchicine also inhibits 
neutrophil motility and activity, leading to a net anti-
inflammatory effect. Colchicine also inhibits urate crystal 
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deposition, which is enhanced by a low pH in the tissues, 
probably by inhibiting oxidation of glucose and subsequent 
lactic acid production in leukocytes. The inhibition of uric 
acid crystals is a vital aspect on the mechanism of gout 
treatment. It is also used as an anti-inflammatory agent for 
long-term treatment of Behçet's disease. The Australian 
biotechnology company “Giaconda” has developed a 
combination therapy to treat constipation-predominant 
irritable bowel syndrome which combines colchicine with 
the anti-inflammatory drug olsalazine. 
The British drug development company “Angiogene” is 
developing a prodrug of colchicine, ZD6126 (also known 
as ANG453) as a treatment for cancer. Colchicine has a 
relatively low therapeutic index. Colchicine is "used 
widely" off-label by naturopaths for a number of 
treatments, including the treatmet. Side-effects include 
gastro-intestinal upset and neutropenia. High doses can also 
damage bone marrow and lead to anaemia. Note that all of 
these side effects can result from hyper-inhibition of mitosis. 
Induction of polyploidy 
Since chromosome segregation is driven by 
microtubules, colchicine is also used for inducing 
polyploidy in plant cells during cellular division by 
inhibiting chromosome segregation during meiosis, half the 
resulting gametes therefore contain no chromosomes, while 
the other half contain double the usual number of 
chromosomes (i.e., diploid instead of haploid as gametes 
usually are) and lead to embryos with double the usual 
number of chromosomes (i.e. tetraploid instead of diploid). 
While this would be fatal in animal cells, in plant cells it is 
not only usually well tolerated, but in fact frequently results 
in plants which are larger, faster growing, and in general 
more desirable than the normally diploid parents for this 
reason, this type of genetic manipulation is frequently used 
in commercial plant breeding. In addition, when such a 
tetraploid plant is crossed with a diploid plant, the triploid 
offspring will be sterile, which may be commercially useful 
in itself by requiring growers to buy seed from the supplier, 
but also can often be induced to create a "seedless" fruit if 
pollinated (usually the triploid will also not produce pollen, 
therefore a diploid parent is needed to provide the pollen). 
This is the method used to create seedless watermelons, for 
instance. On the other hand, colchicine's ability to induce 
polyploidy can be exploited to render infertile hybrids 
fertile, as is done when breeding triticale from wheat and 
rye. Wheat is typically tetraploid and rye diploid, with the 
triploid hybrid infertile. Treatment with colchicine of 
triploid triticale gives fertile hexaploid triticale. 
When used to induce polyploidy in plants, colchicine is 
usually applied to the plant as a cream. It has to be applied 
to a growth point of the plant, such as an apical tip, shoot 
or sucker. Seeds can be presoaked in a colchicine solution 
before planting. As colchicine is so dangerous, it is worth 
noting that doubling of chromosome numbers can occur 
spontaneously in nature, and not infrequently. The best 
place to look is in regenerating tissue. One way to induce it 
is to chop-off the tops of plants and carefully examine the 
lateral shoots and suckers to see if any look different.  
COLCHICINE IN MEDICINES 
Colchicine poisoning and potential acute health effects 
It is extremely hazardous in case of skin contact 
(corrosive, irritant, sensitizer, permeator), of eye contact 
(irritant), of ingestion, of inhalation. The amount of tissue 
damage depends on length of contact. Eye contact can 
result in corneal damage or blindness. Skin contact can 
produce inflammation and blistering. Inhalation of dust will 
produce irritation to gastro-intestinal or respiratory tract, 
characterized by burning, sneezing and coughing. Severe 
over-exposure can produce lung damage, choking, 
unconsciousness or death. Inflammation of the eye is 
characterized by redness, watering, and itching. Skin 
inflammation is characterized by itching, scaling, 
reddening, or, occasionally, blistering, ingestion, of 
inhalation. The substance is toxic to blood, kidneys, lungs, 
the nervous system, the reproductive system, liver, mucous 
membranes. Repeated or prolonged exposure to the 
substance can produce target organs damage. Repeated 
exposure of the eyes to a low level of dust can produce eye 
irritation. Repeated skin exposure can produce local skin 
destruction, or dermatitis. Repeated inhalation of dust can 
produce varying degree of respiratory irritation or lung 
damage. Repeated exposure to an highly toxic material 
may produce general deterioration of health by an 
accumulation in one or many human organs. Repeated or 
prolonged inhalation of dust may lead to chronic 
respiratory irritation. The substance is toxic to blood, 
kidneys, lungs, the nervous system, the reproductive 
system, liver, mucous membranes. 
Action and clinical pharmacology 
Although its exact mode of action in the relief of gout is 
not completely understood, colchicine is known to decrease 
the inflammatory response to urate crystal deposition by 
inhibiting migration of leukocytes, to interfere with urate 
deposition by decreasing lactic acid production by 
leukocytes, to interfere with kinin formation and to 
diminish phagocytosis and the subsequent anti-
inflammatory response. The anti-inflammatory effect of 
colchicine is relatively selective for acute gouty arthritis. 
However, other types of arthritis occasionally respond. It is 
neither an analgesic nor a uricosuric and will not prevent 
progression to chronic gouty arthritis. It does have a 
prophylactic, suppressive effect that helps to reduce the 
incidence of acute attacks and to relieve the residual pain 
and mild discomfort that patients with gout occasionally 
experience. 
CONCLUSION 
Colchicine has been approved as the drug for gout by 
Food and Drug Administration, USA in 2009. Thereafter, 
the interest of the scientist have revived. Since colchicine 
has wide array of properties and applications from ancient 
periods to modern era of medicine, it is necessary to 
understand its pharmacology. It is a pressing need to 
enhance the properties and percentage of colchicine by 
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application of in vitro technologies. In addition to that, 
besides chemical synthesis, in vitro biological synthesis by 
using precursors would be a novel method for the 
production of colchicine. 
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